{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:54:22Z","timestamp":1760147662695,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>There seem to currently be no therapeutic medications found for the severe coronavirus infection in 2019 (COVID-19). In light of this, it has been hypothesized that the immunomodulatory treatment known as tocilizumab can lessen the inflammatory response that occurs in the respiratory system, speed up the process of clinical benefit, lower the risk of death, and avert the need for ventilators. This randomized controlled trial (RCT) studied patients with a proven infection of SARS-CoV-2 and hyperinflammatory reactions. The inclusion criteria included fever (body temperature &gt; 38 \u00b0C), pulmonary infiltrates, or supplemental oxygen. The patients received either conventional treatment with one dose of either tocilizumab (8 mg per kilogram of body weight) or conventional treatment only. The subjects were randomized to receive either treatment with a 1:1 ratio. A time-to-event test was conducted to determine the time to intubation or death. There was an insignificant difference between the investigated groups regarding the time to death, time to mechanical ventilation, and percentage of deaths. The conventional group\u2019s median (IQR) hospital length of stay was 4 (3\u20136) days, whereas the tocilizumab therapy group was 7 (4.75\u201310) days. There was a substantial difference in the mechanical ventilation rates in both groups, which were 17 (34%) and 28 (56%), respectively. In hospitalized patients with severe illness and COVID-19, tocilizumab was ineffective in preventing intubation or death. Trials must be larger, however, in order to exclude the potential benefits or harms.<\/jats:p>","DOI":"10.3390\/healthcare11040607","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T05:27:01Z","timestamp":1676870821000},"page":"607","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-9969","authenticated-orcid":false,"given":"Al Shaimaa Ibrahim","family":"Rabie","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department, Fayium Oncology Center, Fayium 63511, Egypt"},{"name":"Clinical Nutrition Department, Fayium Health Insurance Authority, Fayium 63511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-0260","authenticated-orcid":false,"given":"Hager","family":"Salah","sequence":"additional","affiliation":[{"name":"Pharmaceutical Services Department, King Hamad University Hospital, Al Sayh 24343, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6421-5970","authenticated-orcid":false,"given":"Amira S. A.","family":"Said","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt"},{"name":"Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, Abu Dhabi 64141, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Hassan","family":"Shaaban","sequence":"additional","affiliation":[{"name":"Clinical Oncology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef 62514, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamya Mohamed","family":"Abdou","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef 62514, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa Mahmoud","family":"Khalil","sequence":"additional","affiliation":[{"name":"Public Health and Community Medicine Department, Faculty of Medicine, Beni-Seuf University, Beni-Suef 62514, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelal","family":"Kharaba","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, Abu Dhabi 64141, United Arab Emirates"},{"name":"AAU Health and Biomedical Centre, Al Ain University, Al Ain, Abu Dhabi 64141, United Arab Emirates"},{"name":"Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Afifi","sequence":"additional","affiliation":[{"name":"College of Dental Surgery, City University Ajman, Ajman 18484, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-430X","authenticated-orcid":false,"given":"Mahmoud R.","family":"Sofy","sequence":"additional","affiliation":[{"name":"Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo 11884, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman M. I.","family":"Youssef","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Al-Azhar University, Cairo 11884, Egypt"},{"name":"Department of Biochemistry, College of Medicine, Taif University, Taif 11099, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman S. M.","family":"Bayoumy","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Al-Azhar University, Cairo 11884, Egypt"},{"name":"Department of Biochemistry, College of Medicine, Taif University, Taif 11099, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-685X","authenticated-orcid":false,"given":"Raghda R. S.","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt"},{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University, 6 October City 12858, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3855\/jidc.17148","article-title":"Antibiotic consumption in hospitals during COVID-19 pandemic: A comparative study","volume":"16","author":"Hussein","year":"2022","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e203976","DOI":"10.1001\/jamanetworkopen.2020.3976","article-title":"Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019","volume":"3","author":"Lai","year":"2020","journal-title":"JAMA Network Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jmv.25781","article-title":"The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China","volume":"92","author":"Ding","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.15835\/nbha50112654","article-title":"A polishing the harmful effects of Broad Bean Mottle Virus infecting broad bean plants by enhancing the immunity using different potassium concentrations","volume":"50","author":"Sofy","year":"2022","journal-title":"Not. Bot. Horti Agrobot. Cluj-Napoca"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Netea","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: A meta-analysis","volume":"92","author":"Aziz","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Crit. Care"},{"doi-asserted-by":"crossref","unstructured":"Al-Mokadem, A.Z., Alnaggar, A.E.-A.M., Mancy, A.G., Sofy, A.R., Sofy, M.R., Mohamed, A.K.S., Abou Ghazala, M.M., El-Zabalawy, K.M., Salem, N.F., and Elnosary, M.E. (2022). Foliar Application of Chitosan and Phosphorus Alleviate the Potato virus Y-Induced Resistance by Modulation of the Reactive Oxygen Species, Antioxidant Defense System Activity and Gene Expression in Potato. Agronomy, 12.","key":"ref_14","DOI":"10.3390\/agronomy12123064"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115327","DOI":"10.1016\/j.bmc.2020.115327","article-title":"A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors","volume":"28","author":"Kaur","year":"2020","journal-title":"Bioorganic Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/eji.202149181","article-title":"Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies","volume":"51","author":"Nouveau","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41392-021-00764-4","article-title":"Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108253","DOI":"10.1016\/j.exer.2020.108253","article-title":"Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients","volume":"200","author":"Santiago","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40744-018-0102-x","article-title":"A review of recent advances using tocilizumab in the treatment of rheumatic diseases","volume":"5","author":"Furst","year":"2018","journal-title":"Rheumatol. Ther."},{"unstructured":"Urbaniak, G., and Plous, S. (2013). Research Randomizer, Social Psychology Network. Version 4.0; Web-based application.","key":"ref_20"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3947\/ic.2020.52.2.154","article-title":"Age-related morbidity and mortality among patients with COVID-19","volume":"52","author":"Kang","year":"2020","journal-title":"Infect. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): A randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"unstructured":"Conover, W.J. (1999). Practical Nonparametric Statistics, John Wiley & Sons.","key":"ref_23"},{"key":"ref_24","first-page":"507","article-title":"Effect of biological synthesis of nanoparticles from Penicillium chrysogenum as well as traditional salt and chemical nanoparticles of zinc on canola plant oil productivity and metabolic","volume":"65","author":"Fouda","year":"2022","journal-title":"Egyp. J. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijbiomac.2021.11.197","article-title":"Gamma radiation-induced synthesis of a novel chitosan\/silver\/Mn-Mg ferrite nanocomposite and its impact on cadmium accumulation and translocation in brassica plant growth","volume":"194","author":"Maksoud","year":"2022","journal-title":"Int. J. Biol. Macrom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/thoraxjnl-2020-215266","article-title":"Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19","volume":"76","author":"Khan","year":"2021","journal-title":"Thorax"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijid.2020.12.021","article-title":"Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients","volume":"103","author":"Fisher","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/bcp.15124","article-title":"Efficacy and safety of tocilizumab versus standard care\/placebo in patients with COVID-19; a systematic review and meta-analysis of randomized clinical trials","volume":"88","author":"Vela","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/22221751.2022.2059405","article-title":"Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: A systematic review and meta-analysis","volume":"11","author":"Yu","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03224-7","article-title":"Efficacy of tocilizumab treatment in severely ill COVID-19 patients","volume":"24","author":"Zhao","year":"2020","journal-title":"Crit. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"586221","DOI":"10.3389\/fmed.2020.586221","article-title":"Addition of tocilizumab to the standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis","volume":"7","author":"Boregowda","year":"2020","journal-title":"Front. Med."},{"doi-asserted-by":"crossref","unstructured":"Chober, D., Aksak-W\u0105s, B., Bobrek-Lesiakowska, K., Budny-Finster, A., Ho\u0142da, E., Mie\u017cy\u0144ska-Kurtycz, J., Jamro, G., and Parczewski, M. (2022). Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study. J. Clin. Med., 11.","key":"ref_32","DOI":"10.3390\/jcm11092286"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/jmv.26509","article-title":"Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis","volume":"93","author":"Aziz","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100214","DOI":"10.1016\/j.onehlt.2021.100214","article-title":"Matched cohort study on the efficacy of tocilizumab in patients with COVID-19","volume":"12","author":"Macho","year":"2021","journal-title":"One Health"},{"doi-asserted-by":"crossref","unstructured":"Vivarelli, E., Matucci, A., Lucenteforte, E., Bormioli, S., Virgili, G., Trotta, M., Spinicci, M., Bartoloni, A., Zammarchi, L., and Peris, A. (2022). Effectiveness of Tocilizumab in hospitalized moderate-to-severe COVID-19 patients: A real life study. Panminerva Med.","key":"ref_35","DOI":"10.23736\/S0031-0808.21.04523-7"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102512","DOI":"10.1016\/j.jaut.2020.102512","article-title":"Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab","volume":"114","author":"Morrison","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","article-title":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19","volume":"181","author":"Gupta","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"unstructured":"Horby, P.W., Pessoa-Amorim, G., Peto, L., Brightling, C.E., Sarkar, R., Thomas, K., Jeebun, V., Ashish, A., Tully, R., and Chadwick, D. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): Preliminary results of a randomised, controlled, open-label, platform trial. Medrxiv.","key":"ref_41"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cmi.2020.10.036","article-title":"Efficacy and safety of tocilizumab in COVID-19 patients: A living systematic review and meta-analysis","volume":"27","author":"Tleyjeh","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1016\/S2665-9913(20)30277-0","article-title":"Tocilizumab among patients with COVID-19 in the intensive care unit: A multicentre observational study","volume":"2","author":"Biran","year":"2020","journal-title":"Lancet Rheumat"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/4\/607\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:39:51Z","timestamp":1760121591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/4\/607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["healthcare11040607"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11040607","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}